Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity
G S Longo, J Izzo, Y M Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2000
Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo
F M Sirotnak, H G Wendel, W G Bornmann, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency
R J Motzer, D Niedzwiecki, M Isaacs, et al.
Cancer Research
|
June 15, 1996
Metabolic phenotypes of retinoic acid and the risk of lung cancer
J R Rigas, V A Miller, Z F Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2001
The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice
T C Chou, O A O'Connor, W P Tong, et al.
Molecular Pharmacology
|
February 1, 1992
Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability
X B Kong, L Rubin, L I Chen, et al.
Cancer Research
|
August 15, 1993
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors
R J Motzer, S C Gulati, W P Tong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer
J A Conti, N E Kemeny, L B Saltz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin
S A Laurie, D G Pfister, M G Kris, et al.
Leukemia Research
|
January 1, 1991
Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia
J T Lin, W P Tong, T M Trippett, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity
G S Longo, J Izzo, Y M Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2000
Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo
F M Sirotnak, H G Wendel, W G Bornmann, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency
R J Motzer, D Niedzwiecki, M Isaacs, et al.
Cancer Research
|
June 15, 1996
Metabolic phenotypes of retinoic acid and the risk of lung cancer
J R Rigas, V A Miller, Z F Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2001
The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice
T C Chou, O A O'Connor, W P Tong, et al.
Molecular Pharmacology
|
February 1, 1992
Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability
X B Kong, L Rubin, L I Chen, et al.
Cancer Research
|
August 15, 1993
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors
R J Motzer, S C Gulati, W P Tong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer
J A Conti, N E Kemeny, L B Saltz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin
S A Laurie, D G Pfister, M G Kris, et al.
Leukemia Research
|
January 1, 1991
Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia
J T Lin, W P Tong, T M Trippett, et al.
Page
of 8